|
FY2025
12 months to Dec 26, 2025
|
FY2024
12 months to Dec 27, 2024
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | |||||
| Net income (loss) | |||||
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Share-based compensation expense | |||||
| Goodwill and trademarks impairment charges | |||||
| Asset impairment charges | |||||
| Change in uncertain tax positions | |||||
| Gain on disposal of property, plant and equipment, and subsidiary, net | |||||
| Income (Loss) from Equity Method Investments | |||||
| Deferred income taxes | |||||
| Adjustment of Kunia Well Site liability | |||||
| Gain on release of cumulative translation adjustment | |||||
| Other, net | |||||
| Changes in operating assets and liabilities | |||||
| Receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Other noncurrent assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Investments in and advances to unconsolidated companies | |||||
| Proceeds from sales of property, plant and equipment and subsidiary | |||||
| Cash paid from settlement of derivatives not designated as hedges | |||||
| Insurance proceeds received for damage to property, plant and equipment, net | |||||
| Distributions from unconsolidated companies | |||||
| Other investing activities | |||||
| Net cash (used in) provided by investing activities | |||||
| Net Cash (Used in) Provided by Financing Activities | |||||
| Proceeds from long-term debt | |||||
| Payments on long-term debt | |||||
| Purchase of noncontrolling interest | |||||
| Distributions to noncontrolling interests | |||||
| Payment of deferred financing costs | |||||
| Repurchase and retirement of ordinary shares | |||||
| Share-based awards settled in cash for taxes | |||||
| Dividends paid | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, ending | |||||
| Cash, cash equivalents and restricted cash, beginning | |||||
| Cash, cash equivalents and restricted cash, ending | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash financing and investing activities: | |||||
| Right-of-use assets obtained in exchange for new operating lease obligations | |||||
| Noncash or Part Noncash Divestiture, Amount of Consideration Received | |||||
| Noncash or Part Noncash Acquisition, Investments Acquired | |||||
| Right-of-use assets obtained in exchange for new finance lease obligations | |||||
| Note receivable received in exchange for minority interest in subsidiary | |||||
| Dividends on restricted stock units | |||||
| Non-cash conversion of note receivable in exchange for investment in unconsolidated company | |||||
| Insurance receivable for loss due to property damages | |||||
Loading...